Cardiovascular & Hematological Disorders-Drug Targets
Title:Meet Our Associate Editor
Volume: 18 Issue: 3
Author(s): Patrizia Ferroni
Affiliation:
Export Options
About this article
Cite this article as:
Ferroni Patrizia , Meet Our Associate Editor, Cardiovascular & Hematological Disorders-Drug Targets 2018; 18 (3) . https://dx.doi.org/10.2174/1871529X1803181001165640
DOI https://dx.doi.org/10.2174/1871529X1803181001165640 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
Related Journals
Related Books
31
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Relaxin as a Cardiovascular Drug: A Promise Kept
Current Drug Safety A Possible Application of Memristors for Secondary Lightning Protection
Recent Advances in Electrical & Electronic Engineering Clinical and Experimental Evidence of Supernormal Excitability and Conduction
Current Cardiology Reviews The Role of IRE1 Signaling in the Central Nervous System Diseases
Current Neuropharmacology Current Metabolomic Methodologies & their Application to Thermal Stress
Current Metabolomics Simultaneous Determination of Six Components in Jingzhiguanxin Tablet by High-Performance Liquid Chromatography
Current Pharmaceutical Analysis Asymmetric Dimethylarginine: a Key Player in the Pathophysiology of Endothelial Dysfunction, Vascular Inflammation and Atherosclerosis in Rheumatoid Arthritis?
Current Pharmaceutical Design Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases
Current Pharmacogenomics and Personalized Medicine Ticagrelor and Prasugrel: Two Novel, Most-Promising Antiplatelet Agents
Recent Patents on Cardiovascular Drug Discovery Increased Acetylation of Histone H4 at Lysine 12 (H4K12) in Monocytes of Transgenic Alzheimer’s Mice and in Human Patients
Current Alzheimer Research Blood-Brain Barrier ABC-transporter P-glycoprotein in Alzheimer's Disease: Still a Suspect?
Current Pharmaceutical Design Role of Grina/Nmdara1 in the Central Nervous System Diseases
Current Neuropharmacology Nutritional Control, Gene Regulation, and Transformation of Vascular Smooth Muscle Cells in Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets Behavioral Effects of 2,3-Dihydro- and Oxoisoaporphine Derivatives in Post Stroke-Depressive Like Behavior in Male Balb/c Mice
Current Topics in Medicinal Chemistry Conference Report [IANR V and 9th GCNN Conference with 4th ISCITT Symposium]
CNS & Neurological Disorders - Drug Targets Currently Used Biologic Agents in the Management of Behcet’s Syndrome
Current Medicinal Chemistry Poly(ADP-Ribosyl)ation Enzyme-1 as a Target for Neuroprotection in Acute Central Nervous System Injury
Current Drug Targets - CNS & Neurological Disorders TRPM6 and TRPM7: A Mul-TRP-PLIK-Cation of Channel Functions
Current Pharmaceutical Biotechnology Novel PET Tracers in the Management of Cardiac Sarcoidosis
Current Radiopharmaceuticals Bedtime Hypertension Chronotherapy: Concepts and Patient Outcomes
Current Pharmaceutical Design